€ 19.9
Key Takeaways
Risk factor
Strong & resilient to price shocks
Profitability factor
Very strong margins and returns
About
SCHOTT Pharma AG & Co. KGaA develops, produces, and sells drug containment solutions and delivery systems for injectable drugs to the pharmaceutical and biotechnology industries worldwide. The company offers polymer and glass syringes, ampoules, vials, and cartridges. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of 1SXP.F is 30 and suggests 50% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
